Literature DB >> 33161427

Prevalence of Immunoglobulin G (IgG) Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Evaluation of a Rapid MEDsan IgG Test in Children Seeking Medical Care.

Klara M Posfay-Barbe1, Diego O Andrey2,3, Julien Virzi2, Patrick Cohen2, Fiona Pigny2, Ana R Goncalves2, Selina Pinosch1, Laurence Lacroix1, Silvia Stringhini4, Laurent Kaiser2,3, Nicolas Vuilleumier2, Arnaud G L'Huillier1,2.   

Abstract

In 208 children seeking medical care, the seropositivity rate of anti-SARS-CoV-2 IgG antibodies was 8.7%, suggesting an infection rate similar to that observed in adults but >100-fold the incidence of RT-PCR-confirmed pediatric cases. Compared with the gold-standard combined ELISA + immunofluorescence, the MEDsan IgG rapid diagnostic test performed accurately.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; antibody; pediatrics; rapid diagnostic test; seroprevalence

Year:  2021        PMID： 33161427      PMCID： PMC7717220          DOI： 10.1093/cid/ciaa1702

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  5 in total

1.  Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in a refugee camp, Dagahaley, Kenya.

Authors:  Etienne Gignoux; Frida Athanassiadis; Ahmed Garat Yarrow; Abdullahi Jimale; Nicole Mubuto; Carole Déglise; Denis Onsongo Mosoti; Andrew S Azman; Matilu Mwau; Francisco Luquero; Iza Ciglenecki
Journal:  PLoS One       Date:  2021-12-17       Impact factor: 3.240

2.  Evolution of SARS-CoV-2 IgG Seroprevalence in Children and Factors Associated with Seroconversion: Results from a Multiple Time-Points Study in Friuli-Venezia Giulia Region, Italy.

Authors:  Marzia Lazzerini; Simone Benvenuto; Ilaria Mariani; Giorgio Fedele; Pasqualina Leone; Paola Stefanelli; Giada Vittori; Silvana Schreiber; Alberto Tommasini; Giovanni Rezza; Egidio Barbi; Manola Comar
Journal:  Children (Basel)       Date:  2022-02-12

3.  Longitudinal change in SARS-CoV-2 seroprevalence in 3-to 16-year-old children: The Augsburg Plus study.

Authors:  Vincenza Leone; Christa Meisinger; Selin Temizel; Elisabeth Kling; Michael Gerstlauer; Michael C Frühwald; Katrin Burkhardt
Journal:  PLoS One       Date:  2022-08-11       Impact factor: 3.752

4.  Epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak (Alpha variant) in a primary school: A prospective longitudinal study.

Authors:  Elsa Lorthe; Mathilde Bellon; Grégoire Michielin; Julie Berthelot; María-Eugenia Zaballa; Francesco Pennacchio; Meriem Bekliz; Florian Laubscher; Fatemeh Arefi; Javier Perez-Saez; Andrew S Azman; Arnaud G L'Huillier; Klara M Posfay-Barbe; Laurent Kaiser; Idris Guessous; Sebastian J Maerkl; Isabella Eckerle; Silvia Stringhini
Journal:  PLoS One       Date:  2022-08-17       Impact factor: 3.752

Review 5.  Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis.

Authors:  Master R O Chisale; Sheena Ramazanu; Saul Eric Mwale; Pizga Kumwenda; Mep Chipeta; Atipatsa C Kaminga; Obed Nkhata; Billy Nyambalo; Elton Chavura; Balwani C Mbakaya
Journal:  Rev Med Virol       Date:  2021-07-06       Impact factor: 11.043
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.